Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Jones Lang LaSalle Incorporated    JLL

JONES LANG LASALLE INCORPORATED

(JLL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Jones Lang LaSalle Incorporated : Fort Myers surgery center trades to private equity firm

share with twitter share with LinkedIn share with facebook
08/01/2020 | 12:46pm EDT

ORLANDO, July 29, 2020 - JLL Capital Markets announced today that it has closed the $7 million sale of Paramount Surgery Center, a 9,000-square-foot surgery center in Fort Myers, Florida.

JLL represented the seller, 8250 Realty LLC, who sold the property to IRA Capital.

Paramount Surgery Center is located at 2565 Cleveland Ave. directly across the street from Lee Memorial Hospital, a Level II Trauma Center. Positioned in a busy commercial corridor, the property boasts convenient access to Interstate 95 as well as more than 10,000 businesses within a five-mile radius. The licensed ambulatory surgery center was completed in 2012 and features three operating rooms, step-down recovery, a nurse station, consultation room and reception area.

The JLL Capital Markets team representing the seller included Senior Directors John Krzyminski and Director Max Krzyminski.

'Healthcare properties continue to attract strong investor interest and we anticipate them to be well-positioned to perform in a post-COVID environment as noted in JLL's recent Healthcare Real Estate Outlook,' said Krzyminski.

JLL Capital Markets is a full-service global provider of capital solutions for real estate investors and occupiers. The firm's in-depth local market and global investor knowledge delivers the best-in-class solutions for clients - whether investment advisory, debt placement, equity placement or a recapitalization. The firm has more than 3,700 Capital Markets specialists worldwide with offices in nearly 50 countries.

For more news, videos and research resources on JLL, please visit our newsroom.

Disclaimer

Jones Lang LaSalle Inc. published this content on 29 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 August 2020 16:46:16 UTC

share with twitter share with LinkedIn share with facebook
All news about JONES LANG LASALLE INCORPO
08/12JONES LANG LASALLE INCORPORATED : Class A office building trades in heart of Orl..
PU
08/12JONES LANG LASALLE INCORPORATED : $20.5M refinancing secured for Garabrant in Ne..
PU
08/12JONES LANG LASALLE INCORPORATED : Financing secured for Intermodal Commerce Park..
PU
08/12JONES LANG LASALLE INCORPORATED : Charlotte-area flex portfolio sold for $31.75M
PU
08/12JONES LANG LASALLE INCORPORATED : Mission-critical industrial facility in Georgi..
PU
08/11JONES LANG LASALLE INCORPORATED : Phoenix industrial portfolio refinanced for $1..
PU
08/11JONES LANG LASALLE INCORPORATED : $24.126 refinancing secured for the Enclave at..
PU
08/10JONES LANG LASALLE INCORPORATED : JLL closes the sale of 16 Forge Park for $16.4..
PU
08/10JONES LANG LASALLE INCORPORATED : $26.6M loan secured for suburban Minneapolis c..
PU
08/10JONES LANG LASALLE INCORPORATED : JLL to speak at UBS Financial Services Virtual..
PR
More news
Financials (USD)
Sales 2020 8 196 M - -
Net income 2020 240 M - -
Net Debt 2020 1 017 M - -
P/E ratio 2020 22,9x
Yield 2020 0,14%
Capitalization 5 378 M 5 378 M -
EV / Sales 2020 0,78x
EV / Sales 2021 0,67x
Nbr of Employees 93 400
Free-Float 99,1%
Chart JONES LANG LASALLE INCORPORATED
Duration : Period :
Jones Lang LaSalle Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JONES LANG LASALLE INCORPO
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 135,17 $
Last Close Price 103,86 $
Spread / Highest target 61,8%
Spread / Average Target 30,1%
Spread / Lowest Target 15,5%
EPS Revisions
Managers
NameTitle
Christian Ulbrich President, Chief Executive Officer & Director
Siddharth N. Mehta Chairman
Karen Brennan Chief Financial Officer
Allan Frazier Global Chief Information Officer
Sheila A. Penrose Independent Director